KWTXFDA Panel Backs Vertex Cystic-Fibrosis Drug OrkambiWall Street JournalVertex Pharmaceuticals Inc. VRTX -2.61 % 's experimental cystic fibrosis treatment Orkambi won the backing of a Food and Drug Administration advisory committee on Tuesday, which voted 12-1 to recommend approval. The FDA is expected to make a final ...UPDATE 1-US FDA panel recommends Vertex cystic fibrosis treatmentReutersall 26 news articles »
FDA Panel Backs Vertex Cystic
Rating: 4.5
Diposkan Oleh: Unknown
